NewsDesk  @infectiousdiseasenews A new study, published in Nature Communications and led by Imperial College London researchers, provides the first evidence of a protective role for these T cells. While...

A Michigan Medicine study found that most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months. Researchers analyzed nearly 130...

Recovered COVID-19 patients retain broad and effective longer-term immunity to the disease, suggests a recent Emory University study, which is the most comprehensive of its kind so far. The findings have...

People who survive serious COVID-19 infections have long-lasting immune responses against the virus, according to a new study led by researchers at Massachusetts General Hospital (MGH). The study, published...

By NewsDesk  @infectiousdiseasenews Testing for the SARS-CoV-2, the virus that causes coronavirus disease 2019, or COVID-19 is the main topic of many newscasts, opinion shows, States and their Governors...